Author

Assem El-Baghdady

Observed names: A. A. El-Baghdady, A. El-Baghdady

Institutions: King's College London, Arcus Biosciences (United States)

Observed institutions: King's College London, Arcus Biosciences (United States)

OpenAlex ID: A5067578499

ARC-12: Phase 1/1b Study to Evaluate Safety and Tolerability of AB308 + Zimberelimab (AB122) in Advanced Malignancies

2021 · Sikander Ailawadhi, Paul Foster, et al. · Blood · 1

1028TiP ARC-12: Phase I/Ib dose escalation and dose expansion study to evaluate the safety and tolerability of AB308 + zimberelimab (AB122) in advanced malignancies

2021 · J.A. Call, M.A. Mckean, et al. · Annals of Oncology

Nissen versus Thal Fundoplication as a Surgical Treatment of Gastroesophageal Reflux in Pediatric Age Group : A Comparative Study

2015 · M. S. El-Debeiky, W. A. Ghanem, et al. · Ain Shams Medical Journal

Works count: 3

Citation count: 1

H-index: 1

I10-index: